174 related articles for article (PubMed ID: 20100679)
1. Current and future applications of toxicogenomics: Results summary of a survey from the HESI Genomics State of Science Subcommittee.
Pettit S; des Etages SA; Mylecraine L; Snyder R; Fostel J; Dunn RT; Haymes K; Duval M; Stevens J; Afshari C; Vickers A
Environ Health Perspect; 2010 Jul; 118(7):992-7. PubMed ID: 20100679
[TBL] [Abstract][Full Text] [Related]
2. Toxicogenomics: A 2020 Vision.
Liu Z; Huang R; Roberts R; Tong W
Trends Pharmacol Sci; 2019 Feb; 40(2):92-103. PubMed ID: 30594306
[TBL] [Abstract][Full Text] [Related]
3. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
[TBL] [Abstract][Full Text] [Related]
4. Toxicogenomics: the challenges and opportunities to identify biomarkers, signatures and thresholds to support mode-of-action.
Currie RA
Mutat Res; 2012 Aug; 746(2):97-103. PubMed ID: 22445948
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. [Toxicogenomics and its application in safety evaluation of traditional Chinese medicine].
Lian XP; Ai N; Lu XY; Fan XH
Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(14):2690-5. PubMed ID: 26666010
[TBL] [Abstract][Full Text] [Related]
7. Application of toxicogenomics to genetic toxicology risk assessment.
Thybaud V; Le Fevre AC; Boitier E
Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
[TBL] [Abstract][Full Text] [Related]
8. Toxicogenomics in risk assessment: an overview of an HESI collaborative research program.
Pennie W; Pettit SD; Lord PG
Environ Health Perspect; 2004 Mar; 112(4):417-9. PubMed ID: 15033589
[TBL] [Abstract][Full Text] [Related]
9. Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process.
Luebke RW; Holsapple MP; Ladics GS; Luster MI; Selgrade M; Smialowicz RJ; Woolhiser MR; Germolec DR
Toxicol Sci; 2006 Nov; 94(1):22-7. PubMed ID: 16882865
[TBL] [Abstract][Full Text] [Related]
10. Toxicogenomic biomarkers for liver toxicity.
Kiyosawa N; Ando Y; Manabe S; Yamoto T
J Toxicol Pathol; 2009 Mar; 22(1):35-52. PubMed ID: 22271975
[TBL] [Abstract][Full Text] [Related]
11. Developing a practical toxicogenomics data analysis system utilizing open-source software.
Hirai T; Kiyosawa N
Methods Mol Biol; 2013; 930():357-74. PubMed ID: 23086850
[TBL] [Abstract][Full Text] [Related]
12. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
13. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
Shaller D
Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
[TBL] [Abstract][Full Text] [Related]
14. Database development in toxicogenomics: issues and efforts.
Mattes WB; Pettit SD; Sansone SA; Bushel PR; Waters MD
Environ Health Perspect; 2004 Mar; 112(4):495-505. PubMed ID: 15033600
[TBL] [Abstract][Full Text] [Related]
15. Toxicogenomics in drug discovery and development -- making an impact.
Wills Q; Mitchell C
Altern Lab Anim; 2009 Sep; 37 Suppl 1():33-7. PubMed ID: 19807202
[TBL] [Abstract][Full Text] [Related]
16. Toxicogenomics: regulatory perspective on current position.
Battershill JM
Hum Exp Toxicol; 2005 Jan; 24(1):35-40. PubMed ID: 15727054
[TBL] [Abstract][Full Text] [Related]
17. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomics in Toxicogenomics, Part III: Data Modelling for Risk Assessment.
Serra A; Fratello M; Cattelani L; Liampa I; Melagraki G; Kohonen P; Nymark P; Federico A; Kinaret PAS; Jagiello K; Ha MK; Choi JS; Sanabria N; Gulumian M; Puzyn T; Yoon TH; Sarimveis H; Grafström R; Afantitis A; Greco D
Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32276469
[TBL] [Abstract][Full Text] [Related]
19. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
Youns M; Hoheisel JD; Efferth T
Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
[TBL] [Abstract][Full Text] [Related]
20. Discovering functional modules by topic modeling RNA-Seq based toxicogenomic data.
Yu K; Gong B; Lee M; Liu Z; Xu J; Perkins R; Tong W
Chem Res Toxicol; 2014 Sep; 27(9):1528-36. PubMed ID: 25083553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]